Fingerprint
Dive into the research topics of 'A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: An Eastern Cooperative Oncology Group Study (E1103)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically